drugset / Trial / NCT03834935

Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba

NCT03834935

Phase 2/3 Unknown 40 enrolled St Joseph University, Beirut, Lebanon
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Pityriasis alba (PA) is a common benign skin disorder, that usually affects children and adolescents of darker phototypes. A history of atopic dermatitis is a well-known risk factor, and PA may be a minor manifestation of atopic dermatitis, although it can occur in nonatopic individuals as well. The objective is to evaluate the effect of topical pimecrolimus in the treatment of treatment of PA

Timeline

Start
2019-03-01
Primary completion
2021-02-01
Completion
2021-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pimecrolimus Small molecule 1 % Topical

Indications